Epigenetics Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global epigenetics market looks promising with opportunities in the oncology, metabolic diseases, developmental biology, immunology, and cardiovascular diseases. The global epigenetics market is expected to grow with a CAGR of 13%-15% from 2020 to 2025. The major drivers for this market are increasing prevalence of cancer, increasing research and development activities, and increasing development in pharmaceutical and biotechnology sector.
A total of XX figures / charts and XX tables are provided in more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global epigenetics market report, please download the report brochure.
In this market, kits is the fastest growing product type of epigenetics, whereas oncology is the largest application. Growth in various segments of the epigenetics market are given below:
The study includes trends and forecast for the global epigenetics market by product, technology, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that the kits will remain the highest-growing segment over the forecast period due to increasing prevalence of chronic diseases and increasing government fundings for life science research.
Within this market, oncology will remain the largest segment by application over the forecast period due to rising death cases due to cancer and new product development for treatment of diseases related to oncology.
North America will remain the largest region over the forecast period due to increasing government fundings for research related to epigenetics and technological development in the region.
Features of the Global Epigenetics Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global epigenetics market by product (kits, reagents, enzymes, instruments and consumables, and bioinformatic tools), technology (DNA methylation, histone modification, and other technologies), application (oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and other applications), end user (academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations oncology), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global epigenetics market?
Q.5 What are the business risks and threats to the global epigenetics market?
Q.6 What are emerging trends in this epigenetics market and the reasons behind them?
Q.7 What are some changing demands of customers in this epigenetics market?
Q.8 What are the new developments in this epigenetics market? Which companies are leading these developments?
Q.9 Who are the major players in this epigenetics market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this epigenetics market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global epigenetics market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Kits, Reagents, Enzymes, Instruments and Consumables, and Bioinformatic Tools), Technology (DNA Methylation, Histone Modification, and Other Technologies), Application (Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, and Other Applications), and End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations Oncology)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global epigenetics market looks promising with opportunities in the oncology, metabolic diseases, developmental biology, immunology, and cardiovascular diseases. The global epigenetics market is expected to grow with a CAGR of 13%-15% from 2020 to 2025. The major drivers for this market are increasing prevalence of cancer, increasing research and development activities, and increasing development in pharmaceutical and biotechnology sector.
A total of XX figures / charts and XX tables are provided in more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global epigenetics market report, please download the report brochure.
In this market, kits is the fastest growing product type of epigenetics, whereas oncology is the largest application. Growth in various segments of the epigenetics market are given below:
The study includes trends and forecast for the global epigenetics market by product, technology, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Kits
- Reagents
- Enzymes
- Instruments and Consumables
- Bioinformatic Tools
- DNA Methylation
- Histone Modification
- Other Technologies
- Oncology
- Metabolic Diseases
- Developmental Biology
- Immunology
- Cardiovascular Diseases
- Other Applications
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations Oncology
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- German
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Lucintel forecasts that the kits will remain the highest-growing segment over the forecast period due to increasing prevalence of chronic diseases and increasing government fundings for life science research.
Within this market, oncology will remain the largest segment by application over the forecast period due to rising death cases due to cancer and new product development for treatment of diseases related to oncology.
North America will remain the largest region over the forecast period due to increasing government fundings for research related to epigenetics and technological development in the region.
Features of the Global Epigenetics Market
- Market Size Estimates: Global epigenetics market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global epigenetics market size by various segments, such as product, technology, application, and end user in terms of value.
- Regional Analysis: Global epigenetics market breakdown by the North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different product, technology, application, end user, and region for the global epigenetics market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global epigenetics market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global epigenetics market by product (kits, reagents, enzymes, instruments and consumables, and bioinformatic tools), technology (DNA methylation, histone modification, and other technologies), application (oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and other applications), end user (academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations oncology), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global epigenetics market?
Q.5 What are the business risks and threats to the global epigenetics market?
Q.6 What are emerging trends in this epigenetics market and the reasons behind them?
Q.7 What are some changing demands of customers in this epigenetics market?
Q.8 What are the new developments in this epigenetics market? Which companies are leading these developments?
Q.9 Who are the major players in this epigenetics market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this epigenetics market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global epigenetics market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Kits, Reagents, Enzymes, Instruments and Consumables, and Bioinformatic Tools), Technology (DNA Methylation, Histone Modification, and Other Technologies), Application (Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, and Other Applications), and End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations Oncology)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Epigenetics Market Trends and Forecast
3.3: Global Epigenetics Market by Product
3.3.1: Kits
3.3.2: Reagents
3.3.3: Enzymes
3.3.4: Instruments and Consumables
3.3.5: Bioinformatic Tools
3.4: Global Epigenetics Market by Technology
3.4.1: DNA Methylation
3.4.2: Histone Modification
3.4.3: Other Technologies
3.5: Global Epigenetics Market by Application
3.5.1: Oncology
3.5.2: Metabolic Diseases
3.5.3: Developmental Biology
3.5.4: Immunology
3.5.5: Cardiovascular Diseases
3.5.6: Other Applications
3.6: Global Epigenetics Market by End User
3.6.1: Academic and Research Institutes
3.6.2: Pharmaceutical and Biotechnology Companies
3.6.3: Contract Research Organizations
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Epigenetics Market by Region
4.2: North American Epigenetics Market
4.2.1: Market by Product: Kits, Reagents, Enzymes, Instruments and Consumables
4.2.2: Market by Technology: DNA Methylation, Histone Modification, and Other Technologies
4.2.3: Market by Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, and Other Applications
4.2.4: Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations
4.2.5: The United States Epigenetics Market
4.2.6: The Canadian Epigenetics Market
4.2.7: The Mexican Epigenetics Market
4.3: European Epigenetics Market
4.3.1: Market by Product: Kits, Reagents, Enzymes, Instruments and Consumables
4.3.2: Market by Technology: DNA Methylation, Histone Modification, and Other Technologies
4.3.3: Market by Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, and Other Applications
4.3.4: Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations
4.3.5: The Epigenetics Market of United Kingdom
4.3.6: The German Epigenetics Market
4.3.7: The French Epigenetics Market
4.4: APAC Epigenetics Market
4.4.1: Market by Product: Kits, Reagents, Enzymes, Instruments and Consumables
4.4.2: Market by Technology: DNA Methylation, Histone Modification, and Other Technologies
4.4.3: Market by Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, and Other Applications
4.4.4: Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations
4.4.5: The Chinese Epigenetics Market
4.4.6: The Indian Epigenetics Market
4.4.7: The Japanese Epigenetics Market
4.5: ROW Epigenetics Market
4.5.1: Market by Product: Kits, Reagents, Enzymes, Instruments and Consumables
4.5.2: Market by Technology: DNA Methylation, Histone Modification, and Other Technologies
4.5.3: Market by Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, and Other Applications
4.5.4: Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations
4.5.5: Brazilian Epigenetics Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Epigenetics Market by Product
7.1.2: Growth Opportunities for the Global Epigenetics Market by Technology
7.1.3: Growth Opportunities for the Global Epigenetics Market by Application
7.1.3: Growth Opportunities for the Global Epigenetics Market by End User
7.1.4: Growth Opportunities for the Global Epigenetics Market by Region
7.2: Emerging Trends in the Global Epigenetics Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Epigenetics Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Epigenetics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Abcam Plc.
8.2: Illumina
8.3: QIAGEN N.V.
8.4: Merck & Co.
8.5: New England Biolabs, Inc.
8.6: Epizyme Inc.
8.7: Therm Fisher Scientific, Inc.
8.8: Active Motif. Diagenode, Inc.
8.9:Zym Research Corporation
8.10: Domainex
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Epigenetics Market Trends and Forecast
3.3: Global Epigenetics Market by Product
3.3.1: Kits
3.3.2: Reagents
3.3.3: Enzymes
3.3.4: Instruments and Consumables
3.3.5: Bioinformatic Tools
3.4: Global Epigenetics Market by Technology
3.4.1: DNA Methylation
3.4.2: Histone Modification
3.4.3: Other Technologies
3.5: Global Epigenetics Market by Application
3.5.1: Oncology
3.5.2: Metabolic Diseases
3.5.3: Developmental Biology
3.5.4: Immunology
3.5.5: Cardiovascular Diseases
3.5.6: Other Applications
3.6: Global Epigenetics Market by End User
3.6.1: Academic and Research Institutes
3.6.2: Pharmaceutical and Biotechnology Companies
3.6.3: Contract Research Organizations
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Epigenetics Market by Region
4.2: North American Epigenetics Market
4.2.1: Market by Product: Kits, Reagents, Enzymes, Instruments and Consumables
4.2.2: Market by Technology: DNA Methylation, Histone Modification, and Other Technologies
4.2.3: Market by Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, and Other Applications
4.2.4: Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations
4.2.5: The United States Epigenetics Market
4.2.6: The Canadian Epigenetics Market
4.2.7: The Mexican Epigenetics Market
4.3: European Epigenetics Market
4.3.1: Market by Product: Kits, Reagents, Enzymes, Instruments and Consumables
4.3.2: Market by Technology: DNA Methylation, Histone Modification, and Other Technologies
4.3.3: Market by Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, and Other Applications
4.3.4: Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations
4.3.5: The Epigenetics Market of United Kingdom
4.3.6: The German Epigenetics Market
4.3.7: The French Epigenetics Market
4.4: APAC Epigenetics Market
4.4.1: Market by Product: Kits, Reagents, Enzymes, Instruments and Consumables
4.4.2: Market by Technology: DNA Methylation, Histone Modification, and Other Technologies
4.4.3: Market by Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, and Other Applications
4.4.4: Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations
4.4.5: The Chinese Epigenetics Market
4.4.6: The Indian Epigenetics Market
4.4.7: The Japanese Epigenetics Market
4.5: ROW Epigenetics Market
4.5.1: Market by Product: Kits, Reagents, Enzymes, Instruments and Consumables
4.5.2: Market by Technology: DNA Methylation, Histone Modification, and Other Technologies
4.5.3: Market by Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, and Other Applications
4.5.4: Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations
4.5.5: Brazilian Epigenetics Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Epigenetics Market by Product
7.1.2: Growth Opportunities for the Global Epigenetics Market by Technology
7.1.3: Growth Opportunities for the Global Epigenetics Market by Application
7.1.3: Growth Opportunities for the Global Epigenetics Market by End User
7.1.4: Growth Opportunities for the Global Epigenetics Market by Region
7.2: Emerging Trends in the Global Epigenetics Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Epigenetics Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Epigenetics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Abcam Plc.
8.2: Illumina
8.3: QIAGEN N.V.
8.4: Merck & Co.
8.5: New England Biolabs, Inc.
8.6: Epizyme Inc.
8.7: Therm Fisher Scientific, Inc.
8.8: Active Motif. Diagenode, Inc.
8.9:Zym Research Corporation
8.10: Domainex
